Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CDT1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
mRNA | RHAG | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | EFCAB2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | BAZ2B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | RAP2C | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | ATG3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | MTSS1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | ZIK1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
mRNA | PRPF3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | NPIPA5 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |